With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the anesthesia drugs market in the US is expected to reach a value of 3 billion USD. Growth in the market for anesthesia drugs is affected by factors such as regulation of anesthesia drugs in different states and reaction to such drugs.
The US market for anesthesia drugs can be segmented on the basis of drug type. According to drug type, the anesthesia drugs in United States can be segmented into general inhalation anesthesia drugs, general intraveneous anesthesia drugs, and local anesthesia drugs. The general anesthesia drugs market can be further subdivided into propofol, ketamine, methohexital sodium, fospropofol disodium, pentobarbital, etomidate, fentanyl, and benzodiazepines class (diazepam and midazolam). Local anesthesia drugs market is segmented into articaine, bupivacaine, lidocaine, mepivacaine, and Prilocaine. Increasing demand for anesthesia service and increasing aging population are fueling the market for anesthesia drugs market in the United States. Intraveneous anesthesia drugs accounts for the largest market share. In 2011, the general anesthesia market in the US was valued at 2 billion USD and it is the fastest growing segment in the country. In the general anesthesia segment, ketamine is the preferred drug and it is expected to grow at a steady rate in the coming years.
Key players in the anesthesia drugs market in the United States are Abbot Laboratories, Baxter International, AstraZeneca Plc, and Endo Health Solutions Inc. However, in recent years there are a number of new and emerging companies who are making their presence felt in the market. There are different routes of administering anesthesia to patients. These include inhalation and intravaneous methods. Mask inhalation, laryngeal mask, endotracheal administration, and controlled respiration are some of the modes of administering anesthesia through inhalation. Regulation of anesthesia drugs in different states and recall of certain drugs due to their side effects are some of the challenges which are plaguing the growth of the market. With rise in the number of emergency surgical procedures and increase in cosmetic surgery, the market for anesthesia drugs in the United States is forecasted to grow in the future.
Explore the latest market research reports on anesthesia drugs market in the US @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/anesthesia-drugs